Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nupoor Acharya"'
Autor:
Yogesh Chander, Nupoor Acharya, GSRSNK Naidu, Manish Rathi, Ranjana Minz, Sanjay Jain, Digambar Behera, Aman Sharma
Publikováno v:
Journal of the Association of Physicians of India. 70:62-64
Background: Tuberculosis (TB) can have manifestations closely mimicking autoimmune diseases. The prevalence of autoantibodies in TB varies among different populations. Objectives: To study the prevalence of anti-neutrophilic cytoplasmic antibodies (A
Autor:
Preksha, Dwivedi, Adarsh, Mb, Nupoor, Acharya, Raja, Ramachandran, Ritambhra, Nada, Shankar, Naidu, Shefali K, Sharma, Aman, Sharma, Sanjay, Jain, Varun, Dhir
Publikováno v:
The Journal of the Association of Physicians of India. 69(10)
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis. Since the use of ACE inhibitors in this condition, there has been a significant reduction of mortality rates. However, there is limited data on characteristics a
Autor:
Nupoor Acharya, Aman Sharma, Sanjay Jain, Rajesh Vijayvergiya, Gsrsnk Naidu, Varun Dhir, Manphool Singhal, Ajay Savlania, Bharath A Chhabria, Arghya Chattopadhyay, Valliappan Muthu, Siddharth Jain
Publikováno v:
Rheumatology international. 42(1)
Arterial involvement, although rare, accounts for significant mortality and morbidity in patients of Behcet’s disease (BD). There is paucity of data on arterial BD. The objective of this 5-year retrospective cohort study was to examine the clinical
Autor:
Sandeep Grover, Nupoor Acharya, Sunil Dogra, Harish Kancharla, Aman Sharma, S. K. Mishra, Siddharth Jain
Publikováno v:
Rheumatology international. 42(3)
Fibromyalgia syndrome (FMS) is common in patients of psoriatic arthritis (PsA), but the magnitude of its impact is uncertain. This cross-sectional study evaluated the impact of FMS on health-related quality of life (HRQoL) and disease activity in PsA
Publikováno v:
Annals of the Rheumatic Diseases
Objective To evaluate the efficacy of denosumab in suppressing joint destruction when added to conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy in patients with rheumatoid arthritis (RA). Methods This was a multi-centre,
Publikováno v:
Oral Presentations.
Background Interstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis(SSc).(1) Lung fibrosis in systemic sclerosis shares similar pathogenesis as idiopathic pulmonary fibrosis.(2) Pirfenidone slows the decline i
Publikováno v:
BMJ Case Rep
Infections caused by Mycobacteriumavium complex (MAC) are commonly seen in immunocompromised individuals. Though disseminated MAC infections with splenic granulomas are seen in some patients, MAC infection clinically manifesting as only splenic granu
Publikováno v:
The Lancet Rheumatology. 2:e510
Publikováno v:
Rheumatology. 60:475-475
Publikováno v:
JCR: Journal of Clinical Rheumatology. 27:e192-e192